Abstract Despite the thousands of genes implicated in age-related phenotypes, effective interventions for aging remain elusive, due to the multifactorial nature of longevity and the interconnectedness

The gap

Consensus across the literature

Supporting evidence — 4 representative gaps

• Cardiovascular ageing: hallmarks, signaling pathways, diseases and therapeutic targets (2026) · doi

  With age, the cardiovascular system gradually degenerates, resulting in a series of pathophysiological changes. It may precede or even underlie body-wide, age-related health deterioration. In addition to the increase in time itself, we have innovatively summarized five major etiological factors as well as risk factors that have the potential to promote cardiovascular ageing (Fig. 2). On this basis, we propose several specific management strategies for cardiovascular ageing (Fig. 6). Tables 2 and 3 list FDA-approved drugs and clinical trials targeting cardiovascular ageing. However, it is important to note that categorization does not mean that the etiologies are independent of each other. A poor lifestyle (e.g., diet) can lead to obesity,486 which, as a metabolic syndrome, can accelerate cardiovascular ageing.25 Together, all the etiologies and risk factors form a complex ‘spider web’ of cardiovascular ageing. Obviously, focusing on only one aspect of the problem is limited and ineffective. Therefore, future research should take a holistic approach to propose a macroscopic framework for the etiology of cardiovascular ageing and correspond- ing therapeutic improvement methods. For the first time, we have grouped the twelve hallmarks of cardiovascular ageing into three broad categories, from the micro- to the macrolevel, which are the molecular, cellular and systemic levels (Fig. 4). These findings collectively reveal that cardiovascular ageing is a complex process driven by the accumulation of multiple factors. Importantly, these hallmark features do not act independently but are intricately intertwined and synergistically interact, collectively exerting profound effects on ageing-related diseases (Fig. 5). However, many issues remain to be resolved. For example, the search for more specific ageing biomarkers than p16 remains an important direction for future research. In addition, different cardiac cells undergo senescence, either in naturally senescent or drug-induced senescent hearts.487 It remains unknown whether they play the same role in cardiac function or in the development of CVD.208 Whether reciprocal feedback loops exist between vascular ageing and nondiabetic metabolic disorders represents a compelling hypothesis that warrants further mechanistic investigation.

  Keywords: ageing cardiovascular factors related addition time risk propose speci important etiologies metabolic complex future collectively
• BEYOND LINEAR AGING: Systemic Metabolic Regulation via MSPM and NASP Technological Architecture (2026) · doi

  Future investigations may include: • metabolomic profiling; • proteomic analysis; • inflammatory biomarker assessment; • autonomic nervous system monitoring; • heart-rate variability analysis; • mitochondrial function evaluation; • • controlled nutritional comparison studies; human pilot feasibility trials. The primary scientific objective moving forward should be rigorous characterization of whether systemic metabolic support architectures can measurably influence adaptive resilience during age- associated physiological stress. 11. CONCLUSION The emerging field of nonlinear aging biology suggests that physiological aging may involve coordinated systemic transitions rather than exclusively gradual decline. The observations presented in this paper describe biological outcomes that appear difficult to reconcile with purely linear models of age-associated functional deterioration under severe metabolic stress conditions. While the present work does not establish definitive mechanisms of aging modulation, it proposes that integrated support of metabolic substrate availability and autonomic regulation may represent a relevant direction for future investigation. The central hypothesis underlying this framework is that resilience within aging biological systems may depend not solely on isolated molecular interventions, but on coordinated support of systemic homeostatic architecture. REFERENCES / DATA SOURCES 1.The Stanford Biomolecular Aging Study (Theory): o Shen, X., Wang, C., Zhou, X., & Snyder, M. P. (2024). Nonlinear dynamics of multi-omics profiles during human aging. Nature Aging, 4(8), 1062–1075. o Official Publication Link: https://doi.org/10.1038/s43587-024-00692-2 o Institutional Source (Stanford Medicine) : https://med.stanford.edu/news/all-news/2024/08/massive-biomolecular-shifts-occur-in-our-40s-and-60s--stanford-m.html 2.Empirical Validation Data & Laboratory Verification (Practice): o Naumenko, V. (2026). Immanent Therapy® System and Molecularly Structured Protein Matrix (MSPM) Technology: Long-term biological study results in geriatric models. Patented MT Company. https://zenodo.org/records/20110453 o Open-Access Scientific Repository (Zenodo / CERN): https://zenodo.org/records/20153382 o Official Analytical and Quality Verification Records: European ISO 17025 Certified Laboratory Protocols (Ref: Amino Acid Profile & Mycotoxin Neutralization Analysis, 2019). https://pmtstructure.com/wp-content/uploads/2026/04/Poultry-study.pdf 3.Technological Infrastructure & Verification Frameworks: o Patented MT Company Research Division. (2026). Structural Biochemistry of Filamentous Saccharomyces spp. Matrices. PMT Structure Corporate Repository. Available at: https://pmtstructure.com/updates/ o Commercial Implementation and Visual Technological Blueprint: https://pmtstructure.com/ https://omaridin.com/ o Evaluation Platforms: E

  Keywords: https aging stanford systemic metabolic support biological verification zenodo records pmtstructure future autonomic system evaluation
• BEYOND LINEAR AGING: Systemic Metabolic Regulation via MSPM and NASP Technological Architecture (2026) · doi

  Several important limitations apply to the present work: • The experimental observations were conducted in avian rather than human biological models; The study design does not constitute a randomized blinded clinical trial; • • Mechanistic pathways remain incompletely characterized; • • • • Bioavailability claims require dedicated quantitative validation; NASP mechanisms require electrophysiological and neurophysiological characterization; Independent replication studies are necessary; Correlation does not establish direct causation. These limitations should be considered essential context for interpretation of the findings. 10. FUTURE DIRECTIONS Future investigations may include: • metabolomic profiling; • proteomic analysis; • inflammatory biomarker assessment; • autonomic nervous system monitoring; • heart-rate variability analysis; • mitochondrial function evaluation; • • controlled nutritional comparison studies; human pilot feasibility trials. The primary scientific objective moving forward should be rigorous characterization of whether systemic metabolic support architectures can measurably influence adaptive resilience during age- associated physiological stress. 11. CONCLUSION The emerging field of nonlinear aging biology suggests that physiological aging may involve coordinated systemic transitions rather than exclusively gradual decline. The observations presented in this paper describe biological outcomes that appear difficult to reconcile with purely linear models of age-associated functional deterioration under severe metabolic stress conditions. While the present work does not establish definitive mechanisms of aging modulation, it proposes that integrated support of metabolic substrate availability and autonomic regulation may represent a relevant direction for future investigation. The central hypothesis underlying this framework is that resilience within aging biological systems may depend not solely on isolated molecular interventions, but on coordinated support of systemic homeostatic architecture. REFERENCES / DATA SOURCES 1.The Stanford Biomolecular Aging Study (Theory): o Shen, X., Wang, C., Zhou, X., & Snyder, M. P. (2024). Nonlinear dynamics of multi-omics profiles during human aging. Nature Aging, 4(8), 1062–1075. o Official Publication Link: https://doi.org/10.1038/s43587-024-00692-2 o Institutional Source (Stanford Medicine) : https://med.stanford.edu/news/all-news/2024/08/massive-biomolecular-shifts-occur-in-our-40s-and-60s--stanford-m.html 2.Empirical Validation Data & Laboratory Verification (Practice): o Naumenko, V. (2026). Immanent Therapy® System and Molecularly Structured Protein Matrix (MSPM) Technology: Long-term biological study results in geriatric models. Patented MT Company. https://zenodo.org/records/20110453 o Open-Access Scientific Repository (Zenodo / CERN): https://zenodo.org/records/20153382 o Offi

  Keywords: aging biological stanford https human models future systemic metabolic support zenodo limitations present observations rather
• Network-driven discovery of repurposable drugs targeting hallmarks of aging (2026) · doi

  Abstract Despite the thousands of genes implicated in age-related phenotypes, effective interventions for aging remain elusive, due to the multifactorial nature of longevity and the interconnectedness of molecular components involved.

  Keywords: abstract despite thousands genes implicated related phenotypes effective interventions aging remain elusive multifactorial nature longevity